AHNAK2 and nonpapillary renal cell carcinoma: Wang et al. [14] also found that AHNAK2 is a target gene of HIF1α, which mediates epithelial-mesenchymal transition (EMT) and stem cell characteristics driven by the hypoxia pathway, thereby promoting the progression of ccRCC.